Injective is rising today: what traders are watching

Traders Union
All News
Crypto
Injective Surges 12.76% Today

Highlights

No financial news is available for the specified target dates, according to the article content.
The absence of data prevents any identification of key figures, market movements, or relevant corporate actions.
Market participants receive no new actionable insights due to the unavailability of news on the referenced dates.

Anton Kharitonov, expert at Traders Union, identifies persistent weakness in Injective’s price structure. He notes that INJ is trading below all major moving averages, highlighting sustained selling by participants. The absence of supporting news removes any immediate catalyst for upside. Technical signals remain bearish, with a weak RSI and strong resistance at $6.05 and $6.97. He warns that any breakdown below $4.56 could accelerate declines. "With no fundamental drivers and only tepid technical support, downside risks strongly outweigh rebound chances here," he cautions.

Viktoras Karapetjanc, expert at Traders Union, sees Injective’s recent price volatility as a potential sign of coming opportunities. Although price remains under major moving averages, he argues the market structure supports scope for future rallies if buyers reclaim $6.05 and $6.97. Karapetjanc notes that a lack of negative news flow means sentiment may quickly shift positive on technical triggers. He considers the macro environment neutral, allowing INJ space for upside. "A move above resistance could reawaken bullish momentum — I expect the market to reward patient buyers looking for a breakout," he states.

Parshwa Turakhiya, analyst, highlights the ongoing tug-of-war between buyers and sellers. He points to mixed oscillator signals, with Stoch RSI overbought but regular RSI weak. Short-term swings between $4.56 and $5.71 create quick trading setups. Turakhiya stresses that sentiment remains cautious in the absence of news. "Active traders should target the established range, with tight stops to navigate the volatility," he advises.

Divergent momentum as resistance levels challenge short-term buyers

Technical indicators show the Kijun line as the nearest dynamic resistance at $6.97, with the MA-20 now acting as immediate resistance. There is no golden or death cross present. Momentum signals are mixed — MACD and ADX remain bearish with weak trend support, while oscillators diverge: the RSI is weak at 42.89, CCI points to sustained selling, but the Stoch RSI is overbought at 100. The BBP suggests near-term oversold conditions, indicating a tug-of-war between short-term buyers and longer-term sellers.

Previously it was reported that Injective (INJ) remained under consistent bearish pressure, trading below key moving averages and facing strong resistance at the Ichimoku Kijun level. Momentum indicators, including the MACD, ADX, and RSI, pointed to subdued trend strength and oversold conditions even as the asset posted a notable intraday gain and tested session highs amid heightened volatility.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.